Home  About us  Contact
 

Serotonergic Drugs (serotonergic + drug)

Distribution by Scientific Domains
Medical Sciences100%

Selected Abstracts

Serotonin and Parkinson's disease: On movement, mood, and madness,

MOVEMENT DISORDERS, Issue 9 2009
Susan H. Fox MRCP
Abstract An appreciation of the multiple roles that serotonin (5-HT) may play in Parkinson's disease (PD) has increased in recent years. Early pathological studies in PD demonstrated nonselective reductions of 5-HT in brain tissue but little correlation to comorbidities such as dyskinesia and mood disturbance. This, combined with treatment failures using serotonergic drugs in comparison to levodopa, meant the field was largely neglected until recently. The multitude of subtypes of 5-HT receptors in the brain and an increased understanding of the potential function 5-HT may play in modulating other neurotransmitter systems, including dopamine, GABA, and glutamate, have meant an expansion in efforts to develop potential serotonergic drugs for both motor and nonmotor symptoms in PD. However, several unanswered questions remain, and future studies need to focus on correlating changes in 5-HT neurotransmission in both pathological and in vivo imaging studies with a full clinical phenotype. © 2009 Movement Disorder Society [source]

The Enteric Nervous System III: A Target for Pharmacological Treatment

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 1 2003
Mark Berner Hansen
Indeed, the enteric nervous system has become a promising target in the treatment of many gastrointestinal symptoms and disorders. Some of these new therapeutic concepts, such as botulinum toxin for achalasia and serotonergic drugs for functional bowel diseases, are already in clinical use. This paper is part 3 of three Minireviews in Pharmacology & Toxicology, and presents the neurogastrointestinal pharmacological therapeutic options in gastrointestinal pain, functional gastrointestinal disorders, inflammatory bowel diseases, cancer and related conditions with focus on future drug targets. The diagnosis of gastrointestinal neuropathy, the role of serotonin and related neuroendocrine transmitters, serotonergic drugs, and neurotrophic factors in neurogastrointestinal pharmacology will be addressed in this context. [source]

Treatment of functional GI disease: the complex pharmacology of serotonergic drugs.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Issue 6 2002
Reply from author
No abstract is available for this article. [source]